
NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Case Study: Pharmacotherapy for Dyslipidemia and Metabolic Dysfunction-Associated Steatotic Fatty Liver Disease
Clinical Case The patient is a 67-year-old white gentleman with type 2 diabetes mellitus (T2DM), hypertension (HTN), 20-pack-year smoking history, and dyslipidemia. He presented to…
Novel Advancements in GLP-1 Receptor Agonist Treatment
Introduction Obesity is a complex, chronic medical condition. Although defined by a BMI >30 kg/m2, it is now understood to be much more than a…
Teach ASCVD Program
About the Program – Leveraging Implementation ScienceThe NLA Health Quality and Research (HQR) committee is testing an education intervention for physicians, physician assistants, and nurse…
Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective
A heart-healthy lifestyle, beginning at an early age and sustained throughout life, may reduce risk for cardiovascular disease in youth.
Addressing Medication Adherence in Obesity and Diabetes
Medication Adherence Medication adherence is a vital part of managing a patient’s medication regimen but is often overlooked. Between addressing patient symptoms, assessing vital signs,…
Medical Nutrition Therapy for Pre-Diabetes, Diabetes, and Obesity in Adults
Medical nutrition therapy (MNT) by trained registered dietitian nutritionists (RDN) is an integral part of a multidisciplinary health care team. Research has shown that this…
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association
This Clinical Perspective provides an update with a focus on nutrition interventions for the three most common dyslipidemias in adults.
Case Study: A Patient with Familial Hypercholesterolemia and Statin-Associated Muscle Effects: Pharmacotherapy and Lifestyle
Atherosclerotic cardiovascular disease (ASCVD) is an umbrella term for atherosclerotic conditions that affect the cardiovascular system, including ischemic heart disease, peripheral artery disease, and ischemic…